NCT04728828View on ClinicalTrials.gov

COVADIAL - Immunogenicity of COVID-19 Vaccine in Hemodialysis Patients

CompletedOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

January 25, 2021

Primary Completion Date

January 15, 2023

Study Completion Date

August 15, 2023

Conditions
Covid19
Interventions
BIOLOGICAL

Serological COVID-19 vaccine immunogenicity

Serological test

Trial Locations (1)

29000

Centre Hospitalier de Quimper, Quimper

All Listed Sponsors
collaborator

Centre Hospitalier Régional et Universitaire de Brest

OTHER

lead

Centre Hospitalier de Cornouaille

OTHER

NCT04728828 - COVADIAL - Immunogenicity of COVID-19 Vaccine in Hemodialysis Patients | Biotech Hunter | Biotech Hunter